Congratulations to Professor Dr. Ali Abdul-Hussein Al-Janabi on the occasion of obtaining the third patent

The Deanship of the Faculty of Medicine, University of Karbala, and the faculty members, headed by the Dean of the Faculty of Medicine, Prof. Dr. Riyad Dahoud Al-Zubaidi, congratulate Prof. Dr. Ali Abdul-Hussein Al-Janabi on the occasion of obtaining the third patent to be added to the two previous patents to be a new asset to our dear college. Mentioned in the summary below:

The Central Organization for Standardization and Quality Control granted an Iraqi patent to Professor Ali Abdul-Hussein Sadiq, a teaching staff member at the College of Medicine entitled (Preparation of amphotericin B ointment for the treatment of skin infections with Dormatophytosis)

The patent relied in its idea on two main axes, the first depends on testing the possibility of converting the pharmacological form of the antifungal amphotericin B   from the form of injection needles currently used to the form of a superficial medicinal ointment, and the second axis depends on changing the purpose of the drug, instead of using it to treat Systemic fungal infections of the human body, can it be used to treat skin infections with dermatophytoses   

The effectiveness of amphotericin B antibiotic was tested for the treatment of ringworm infections in both animals and humans by preparing it in a creamy form with a concentration of 1%, which measurements of its physical properties proved to be a good quality of ointments. A very high complete recovery after 6 days without a recurrence of the infection and up to 90 days, and the second step was to use the new ointment to treat injuries in humans and prove its therapeutic efficacy in healing all patients and in a shorter period of time than the Clotramazole ointment (1%) currently used to treat this type of infection. Fungal infections.

The results of this study demonstrated the efficacy of amphotericin B cream for treating ringworm in comparison with commonly used antifungals such as clotramazole 1% cream, in addition to the efficacy of amphotericin B cream in preventing the recurrence of infection after recovery.